Good Lifestyle

July in America is a difficult start because the new coronavirus continues to spread around the United States, reaching 250,000 new cases in less than a week. In efforts to solve the problem by global vaccination of the scale,Several companies and research institutesAre races to develop CVIV-19 vaccines. As the home refuge is adjourned and the states are trying to reopen the economy, doctors and scientists agree that at least one functional vaccine would accelerate the company to return to normal.But how far do we need to get a Covid-19 vaccine?

Some things must arrive first

Today, masks are treated like homemade vaccines. In fact, you can think of them as holders to place for the real Jab. Although staying away from friends and family was not on your projects for this year, do not share your air with other people is the smart thing to do until we get a vaccine For the new coronavirus. Dr. Anthony Fauci, the country's first expert in infectious diseases, rightlyNotedthat no vaccine would be effective in the United States, so too many people refused to obtain it. For a vaccination at work, we must all agree to get it once available and I hope thatgood optionsare in progress - it seems to be that when humanity puts its emphasis in something good, we do it.

There are many challenges to solve the problem with this virus, including itsFast propagationand ourFailure to contain the coronavirusso that vaccine researchers are tryingNew ways to recruit thousands of healthy volunteersnecessary to finish testing coronavirus drugs at the end of the stages of development. While testing new drugs on healthy volunteers, researchers must ensure that they are trying on a wide variety of people, including sex, age groups, underlying ethnic health conditions. do not forget thatBIPOC communities in the United States are 3 times more likely to contract coronavirusthat their white neighbors - and almost twice as likely to die, according to new data published byThe New York Times.Thus, much of the job that vaccine scientists work is to make sure to test vaccines on each community.

The first human study of one of the candidate vaccines, focused on whether he's sure, he started writing topics in May, but they are not alone - in fact, about17 vaccines in human testsand more than130are developing by researchers and different companies.

Who gets him first?

Cover theUnited States populationWe will need at least 330 million doses, if the approved vaccine requires only one dose. Then we must understand and come to an agreement on which gets it first. Once a vaccine is approved, theAmerican Centers for Disease Control and Preventionwill have to decide who should get it first. Given the mortality data we have available so far, it is prudent to assume that people who areMore likely to die so infected with COVID-19can receive it firstElderly populations living in retirement homes.Essential workersAnd health care providers will probably be considered first. However, the ultimate decision on WHO is vaccinated first, if a COVID vaccine is available, will be conducted at the state and local level.

How much will it cost?

Because drug pricing is not made in a simple way, aThe bipartite coalition in the House has recently proposed two new bills toProvide affordable CVIV-19 vaccine pricing.Drug pricing has been a challenge for many yearsand it's embarrassing for other diseases such asCancerandDiabetes. For those familiar with the fight to obtain overloaded drugs, are also familiar with the term"Financial toxicity"-What reflects another obstacle that patients need to overcome when they get sick. Another layer to this is thatMedicareis not allowed to participate in price negotiations for medicines covered by its partial drug plan. Until the vaccine candidate is tested and judged, we will not know how much it will cost.

Candidates for the vaccine

ManyCoronavirus vaccine candidatesAre defined to enter large clinical trials in the United States this summer, with at least one other hundred hundreds that are still developing and have not started human tests.

The development of preclinical vaccines seeks to collect data to support the feasibility and security of the candidate, entering Phase I of clinical trials that evaluate the immune safety and response, on Phase II, they can test effectiveness on a Group of medium-sized people and phase III clinical trial that will evaluate thousands of individuals safety and efficiency of the drug. After that, government agencies will review clinical test data and emission approvals are justified.

TheUniversity of Oxford / AstrazenecaPhase III is planned to start the United States in August 2020, while theVaccine candidate against Pfizeris defined to begin phase III studies later this month in the United States as well asModerna / Niaid drug candidateARND-1273.Johnson & Johnson Viral Vector VaccineThe candidate is promised to launch phase III studies in the United States in September.

Whatever the vaccination vaccination candidate will be published first and made available for all, something we should be aware of it is thatThis can take several different vaccines and distributed by different laboratories to eradicate Cvid-19 effectively, as Dr. Faisci announced in June 2020.

And during this time, "the federal governmentwill pay the Maker Novavax vaccine $ 1.6 billionTo accelerate the development of 100 million doses of coronavirus vaccine earlier next year, the company said Tuesday, "reports theNew York Times. "The agreement is most important that the Trump administration has so far has done with a company as part of the speed of the operating chain, the federal tentacular efforts to make coronavirus vaccines and treatments available to the American public as quickly as possible. In doing so, the government has placed an important bet on Novavax, "and signed a $ 450 million contract with Regenton for the development of COVID-19 therapy.

When can we expect it to be?

The development of vaccines usually takes many years and, in some cases, the vaccine never comes to realize. An example of it is that we haveNot successfully developed an HIV vaccineAnd researchers work there for more than 30 years. Fortunately, patients living withHIV has the same life expectancy as non-showcase positivePeople, due to progress in prevention and treatment.

The challenge is not only developing and approving a new vaccine but also to global manufacturing and distribution. The federal agency that regulates new drugs, the Food and Drug Administration will approve the new vaccine for use and label as "safe and effective", and the minimum standards set by the FDA for approval, include the obligationThe vaccine must be at least 50% better than a placebo for CVIV-19 prevention.

So, when can we expect one? Moderna is promising a vaccine over the quarter 2020 and the Oxford University shot will probably be ready Q1 2021.

The first thoughts of the doctor

In the history of humanity, there have never been so many doctors and scientists who worked hard and quick to solve a health problem. There is only just half a year sinceSARS-COV-2 was discovered for the first timeAnd we already have 17 vaccine candidates in human tests, with dozens of more under development.

Data that companies and researchers shared, it is unlikely that we would never find coronavirus vaccine. There is reason to convince that we will find new ways to prevent infection, the severity of diseases and the attenuation of viral replication, in one way or another.

If these vaccines are not safe or efficient, the focus will likely be on the search for effective treatments, in the same way it has been made for HIV. Whatever immunization results, to successfully eradicate COVID-19, the country needs a federal working group dedicated to COVID tests, antibody monitoring and contact tracing, if we want to return to what We remember normal life.

Until we have a Covid-19 vaccine, be sure to wear a mask and not share your face coatings and social distance contain the propagation of the virus. And t o Cross this pandemic at your healthier, do not miss these Things you should never do during the pandemic coronavirus .